Canadian NET cancer patients are dying with an average life span of five to seven years from time of diagnosis. By 2025, with an investment of 5 million dollars, we can develop better diagnostic tools for early detection of NETs, and state-of-the art personalized therapies using various approaches. More importantly, future research directions will help us understand the causes (genetic, cellular, environmental) that turn our body’s normal neuroendocrine cells into a cancerous (NET) cell. Understanding the cause will allow us to focus on prevention of NET cancer.
Research is the game changer. Without it, we will never understand the cause of NET cancer. Nor will we be able to expedite diagnosis and develop state-of-the-art treatments. Research is the only thing that will make a difference. CNETS priority is to fund high priority research projects that will lead to improved quality of life and survival for NET cancer patients in Canada.
COMING SOON: A donor wall on our website to acknowledge our donors give to NET research
Your gift will make a tremendous difference to NET patients. Thank you in advance!